MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • MassDevice Today
    • Cardiovascular
    • Clinical Trials
    • Legal News
    • Orthopedics
    • Regulatory/Compliance
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • More MedTech
    • Cosmetic/Aesthetic
    • Diabetes
    • Dialysis
    • Distribution
    • Imaging
    • Otolaryngology Ear, Nose & Throat
    • Pharma
    • Respiratory
    • Wound Care
  • Blog
  • DeviceTalks Podcasts
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • White Papers
  • DeviceTalks

T2 Biosystems takes aim at sepsis with sensitive diagnostic tech

October 1, 2018 By Sarah Faulkner Leave a Comment

Sepsis, a complication of an infection caused by foreign cells infiltrating a person’s bloodstream, affects nearly two million people each year in the U.S. If not addressed quickly, the infection triggers the body’s immune system to begin attacking its own organs, resulting in a slow, weeks-long death. The challenge for clinicians is identifying the source […]

Filed Under: Diagnostics, Featured, Pharmaceuticals, Wall Street Beat Tagged With: T2 Biosystems Inc.

T2 Biosystems prices $46m offering

June 4, 2018 By Fink Densford Leave a Comment

T2 Biosystems today priced an upcoming $45.8 million offering, looking to float approximately 6.1 million shares. In the offering, T2 Biosystems will offer shares at a price of $7.50 per share, slightly lower than the May 29 closing price of $8.06 per share. As of 11:11 a.m. EDT, T2 Biosystems shares are trading at $8.34 pre […]

Filed Under: Business/Financial News, Funding Roundup Tagged With: T2 Biosystems Inc.

T2 Biosystems wins FDA nod for T2 Bacteria panel, plans offering

May 30, 2018 By Fink Densford Leave a Comment

T2 Biosystems today announced it won FDA clearance for its T2 Bacteria panel for detecting bacterial species in human blood from patients with suspected bloodstream infections, and announced plans for an upcoming offering. The Lexington, Mass.-based company said that it won approval for the detection of specific sepsis-causing bacterial pathogens as acquired from a whole […]

Filed Under: Blood Management, Diagnostics, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: T2 Biosystems Inc.

T2 Biosystems touts results from 4 studies of its T2Dx diagnostics system

March 30, 2018 By Fink Densford Leave a Comment

T2 Biosystems this week released results from four studies of its T2Dx blood diagnostics system designed to detect pathogens that cause sepsis, touting clinical and performance advantages when compared to traditional blood cultures. The four studies were published in the Journal of Antimicrobial Chemotherapy, the Lexington, Mass.-based company said. A study conducted at Rome’s Gemelli Hospital […]

Filed Under: Clinical Trials, Diagnostics Tagged With: T2 Biosystems Inc.

T2 Biosystems lands $2m grant for ‘superbug’ test

March 8, 2018 By Brad Perriello Leave a Comment

T2 Biosystems won a $2 million grant to develop a test using its T2Dx MR-based technology to detect strains of drug-resistant bacteria or so-called “superbugs.” The grant is from Carb-X, a Boston University-based public-private partnership aimed at furthering anti-bacterial R&D that’s jointly funded by the U.S. Health & Human Services Dept.’s Biomedical Advanced Research & Development […]

Filed Under: Diagnostics, Funding Roundup Tagged With: T2 Biosystems Inc.

T2 Biosystems tops The Street with Q4, 2017 earnings

March 6, 2018 By Fink Densford Leave a Comment

T2 Biosystems Inc. (NSDQ:TTOO) today reported fourth quarter and full year 2017 earnings that topped expectations on Wall Street. The Lexington, Mass.-based company reported sales of $1.7 million for its fourth quarter, up 87% when compared with the same quarter least year. Costs for the quarter, excluding the cost of product revenue, were $9.8 million, down […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: T2 Biosystems Inc.

InVivo Therapeutics lifts Toselli to permanent prez, CEO | Personnel Moves February 6, 2018

February 6, 2018 By Fink Densford Leave a Comment

InVivo Therapeutics (NSDQ:NVIV) said yesterday it made Dr. Richard Toselli’s spot in the corner office permanent, lifting him from acting CEO to prez and CEO. Dr. Toselli will maintain his position on the company’s board and as its chief medical officer, the position he was given when he joined the company last July. Prior to joining InVivo, […]

Filed Under: Business/Financial News Tagged With: Alcon, Baxter, Boston Scientific, Faxitron, GE Healthcare, InVivo Therapeutics, johnsonandjohnson, Lima Corporate, Luxottica, Medizone, Medtronic, performancehealth, Respicardia, Robocath, Sanofi-Aventis, T2 Biosystems Inc.

T2 Biosystems prices $18m offering

September 19, 2017 By Fink Densford Leave a Comment

T2 Biosystems Inc. (NSDQ:TTOO) last week priced a public offering looking to raise $17.5 million. The Lexington, Mass.-based company said it is offering 4.4 million shares of its common stock at $4 per share with a 30-day underwriters option to purchase an additional 656,250 shares at the same price. T2 Biosystems said it expects the offering […]

Filed Under: Business/Financial News, Diagnostics Tagged With: T2 Biosystems Inc.

T2 Biosystems files 510(k) for T2Bacteria Panel

September 11, 2017 By Fink Densford Leave a Comment

T2 Biosystems Inc. (NSDQ:TTOO) said today it filed a 510(k) appliation with the FDA for its T2Bateria Panel rapid diagnostic solution designed to identify pathogens assocaited with Sepsis. The T2Bacteria panel is designed to run on the FDA-cleared T2Dx instrument to provide diagnosis of sepsis pathogens within hours, reducing the time for patients with bloodstream infections […]

Filed Under: Diagnostics, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: T2 Biosystems Inc.

CDC to use T2 Biosystems in testing for superbug Candida auris

September 6, 2017 By Fink Densford Leave a Comment

T2 Biosystems Inc. (NSDQ:TTOO) said today that the US Centers for Disease Control and Prevention will use its T2Dx Instrument to test and monitor for the emergence and outbreaks of the antibiotic-resistant superbug Candida auris. The Lexington, Mass.-based company said the use of the T2Dx “represents multiple, new applications” for the platform. The system will be […]

Filed Under: Business/Financial News, Diagnostics Tagged With: T2 Biosystems Inc.

T2 Biosystems wins CE Mark for MR-based bacteria detector, closing in on FDA bid

July 18, 2017 By Fink Densford Leave a Comment

T2 Biosystems Inc. (NSDQ:TTOO) said today it won CE Mark approval in the European Union for its T2Bacteria Panel magnetic resonance-based bacterial detector, and said that it has entered the final stages of its FDA pivotal trial as it seeks 510(k) approval from the agency. The T2Bacteria Panel is designed to run on the company’s T2Dx […]

Filed Under: Diagnostics, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: T2 Biosystems Inc.

  • 1
  • 2
  • 3
  • 4
  • Next Page »
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Privacy
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS